Dr. Albert Kim, M.D., Ph.D.
Claim this profileWashington University School of Medicine
Area of expertise
Glioblastoma
Albert Kim, M.D., Ph.D. has run 6 trials for Glioblastoma. Some of their research focus areas include:
Gamma Knife Treatment
Albert Kim, M.D., Ph.D. has run 1 trial for Gamma Knife Treatment.
Affiliated Hospitals
Washington University School Of Medicine
Clinical Trials Albert Kim, M.D., Ph.D. is currently running
Sonobiopsy
for Glioblastoma
This clinical study to evaluate sonobiopsy is significant because sonobiopsy will fundamentally enhance the clinician's insight into the molecular features of an intracranial lesion to tailor treatment approaches and optimize outcomes. In addition to the standard diagnostics of anatomic imaging and surgical histology, sonobiopsy has the potential to become the third pillar for brain tumor management by radically advancing the ability to easily and regularly acquire tumor genetic and molecular signatures. This enhanced capability will have a dramatic impact on patient survival and quality of life.
Recruiting
1 award
N/A
Azeliragon + Chemoradiotherapy
for Glioblastoma
Preclinical data have demonstrated the combination of azeliragon, a RAGE inhibitor, with radiation therapy (RT) can effectively reduce immune-suppressive myeloid cells and restore T-cell activation to improve tumor control in murine glioma models. Ongoing clinical studies of azeliragon with RT alone and RT plus temozolomide (TMZ) to treat patients with newly diagnosed glioblastoma (GBM) have demonstrated safety and tolerability. The purpose of this window-of-opportunity study is to validate that the combination of azeliragon with RT and TMZ would modulate immune-suppressive myeloid and T cells in the tumor microenvironment in patients with GBM.
Recruiting
1 award
Phase < 1
6 criteria
More about Albert Kim, M.D., Ph.D.
Clinical Trial Related
2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Albert Kim, M.D., Ph.D. has experience with
- Surgery
- Sonobiopsy
- Personalized Neoantigen DNA Vaccine
- Proton Therapy
- Avelumab
- Disulfiram
Breakdown of trials Albert Kim, M.D., Ph.D. has run
Glioblastoma
Gamma Knife Treatment
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Albert Kim, M.D., Ph.D. specialize in?
Albert Kim, M.D., Ph.D. focuses on Glioblastoma and Gamma Knife Treatment. In particular, much of their work with Glioblastoma has involved Stage IV patients, or patients who are IDH negative.
Is Albert Kim, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Albert Kim, M.D., Ph.D. is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Albert Kim, M.D., Ph.D. has studied deeply?
Yes, Albert Kim, M.D., Ph.D. has studied treatments such as Surgery, Sonobiopsy, Personalized neoantigen DNA vaccine.
What is the best way to schedule an appointment with Albert Kim, M.D., Ph.D.?
Apply for one of the trials that Albert Kim, M.D., Ph.D. is conducting.
What is the office address of Albert Kim, M.D., Ph.D.?
The office of Albert Kim, M.D., Ph.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.